New TCR-T Therapy Afami-cel For Advanced Sarcoma With Promising And Long-Lasting Results!
Afamitresgene Autoleucel, also known as Afami-cel or ADP-A2M4, is a novel TCR-T cell immunotherapy that has produced durable and promising results in patients with advanced synovial sarcoma or mucinous/round cell liposarcoma